Effects of benefits and harms on older persons' willingness to take medication for primary cardiovascular prevention - Wikidata - wikimedia - TriplyDB

Effects of benefits and harms on older persons' willingness to take medication for primary cardiovascular prevention

Effects of benefits and harms on older persons' willingness to take medication for primary cardiovascular prevention

http://www.wikidata.org/entity/Q35004412

about

Statins for primary cardiovascular prevention in the elderly Systematic review of clinical practice guidelines recommendations about primary cardiovascular disease prevention for older adults Patient-centered care for people living with multimorbidity Systolic BP and Mortality in Older Adults with CKD.Complex antithrombotic therapy: determinants of patient preference and impact on medication adherence Primary prevention: do the very elderly require a different approach?The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes Personalized medicine in Europe: not yet personal enough?Health outcome prioritization as a tool for decision making among older persons with multiple chronic conditions Patient perceptions of osteoporosis treatment thresholds Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults.Relationship between universal health outcome priorities and willingness to take medication for primary prevention of myocardial infarction.Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity.Patients' perceptions of their "most" and "least" important medications: a retrospective cohort study.Managing older adults with CKD: individualized versus disease-based approaches Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials.Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer "Knowing is better": preferences of diverse older adults for discussing prognosis Reconsideration of key articles regarding medication-related problems in older adults from 2011.Epidemiology and Public Health Concerns of CKD in Older Adults.Workshop Report: concepts and methods in the economics of nutrition--gateways to better economic evaluation of nutrition interventions.Drug prescription rates in secondary cardiovascular prevention in old age: Do vulnerability and severity of the history of cardiovascular disease matter?Prognostic value of cardiovascular disease status: the Leiden 85-plus study.Rating the preferences for potential harms of treatments for cardiovascular disease: a survey of community-dwelling adults.Discussing overall prognosis with the very elderly.Clinical pharmacology in old persons.Patient prioritization of comorbid chronic conditions in the Veteran population: Implications for patient-centered care.Providing additional information about the benefits of statins in a leaflet for patients with coronary heart disease: a qualitative study of the impact on attitudes and beliefs.Influence of medication risks and benefits on treatment preferences in older patients with multimorbidity.Angiotensin receptor blockers in clinical practice--implications of the ONTARGET study.Medication prescribing in frail older people.Intentional non-adherence to medications by older adults.Prescribing for older people discharged from the acute sector to residential aged-care facilities.Statins in the elderly: a patient-focused approach.Blood Pressure in Older Adults: the Importance of Frailty.Effect of the Tool to Reduce Inappropriate Medications on Medication Communication and Deprescribing.Preventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient Preferences.Eliciting Preferences of Multimorbid Elderly Adults in Family Practice Using an Outcome Prioritization Tool.Improving Medication Adherence in Cardiometabolic Disease: Practical and Regulatory Implications.Evaluating a combined (frequency and percentage) risk expression to communicate information on medicine side effects to patients.

P2860

Q26783401-BE997671-81AB-48FD-A553-3DB6F2459381 Q26796403-30CFC85F-38C1-4D6F-9BEA-4FE3E041214B Q27000743-6A8FDA50-778C-4904-9957-A6C53AB303AF Q27335475-E7800E9B-CBD8-4875-8CD5-ACCDCD2561B5 Q27336043-BE9DDD49-5D1B-4749-ACDB-DD635F4DA77D Q28080456-55D1FF1B-3774-4FA9-9CDF-C38BAC6010E7 Q28550096-2A4152D8-3D36-4EC7-B85F-62EB64D5F129 Q33577079-44740484-37BD-4275-B2DB-C7B4887A1E12 Q33678109-A1024A7C-258A-41D8-B3DF-96E5A76DC263 Q33766971-0B02A4F0-5B84-48A7-B730-1D0645B5977E Q34061043-62C89FF1-FECA-409D-A11E-4FE044E4BC8B Q34232018-B895DAED-7F72-4E0A-B132-CEAE09210488 Q34418562-C911F5F7-B7FB-43D9-9365-3E3CE81D9C62 Q34465811-7CB51F5B-546C-4561-9508-E331C6A86F87 Q35680995-CAEEE763-335F-4038-843C-D52662426604 Q35684200-E53B451F-F6E9-444F-9DDB-B0A9549FBA2C Q35794066-54C7F55F-669E-49F4-9713-056B5907459D Q35888174-A86D39F4-423E-4239-9733-272D39AA4A91 Q36043785-D78E6329-AFCA-4920-9F31-E098E1773206 Q36410394-2A3734F3-3EE1-4860-831B-88AFF589E764 Q36443118-5C79A14E-BCC0-4AC3-BA34-52F08BB2A097 Q36572076-A0D62580-F0A2-4C55-8DE4-932FCF8E795B Q36993441-EBF5F776-3CE0-41E2-8911-C2D1B680282C Q37110416-9159FEF1-B31B-498F-868A-23DA443F2036 Q37141258-FE7A0BC1-4130-4CF6-B314-0A2C9F393180 Q37288132-9DE06100-5301-4A11-AA0D-77A69A134D52 Q37461524-49043609-4A7B-42AE-9622-EEBFB3279FE9 Q37517320-1C4A1710-D723-421A-9997-F636A5B05E48 Q37608563-E6DE2E57-0B04-4AA1-A191-A1F216F859F8 Q37994859-782C070F-C6E0-484A-A9A6-1F0B1002A534 Q38042383-CF59627B-D927-46E5-8762-3D41E84B0151 Q38190869-3824D8CB-CD39-465B-8B53-5E352C99D7AC Q38258821-7F154159-108B-4AC5-A86C-F6FA1BA8BC2D Q38261869-1E7C9235-1E21-48BB-AD4C-FFACAB63268F Q38525968-ACEDFE74-B211-4388-B611-316907D31105 Q38626494-00B2C73E-FDBE-447C-92B3-0196FAB8B712 Q38893197-3D192E59-AE29-485F-8B8E-B204293D6413 Q38950263-8E711FC3-2590-4A33-9994-B3EA5A178570 Q39105190-DD8AFE6D-C566-47C0-9B4A-21130A1F6ED0 Q44196521-5709B93E-DAFB-44CE-B570-F3022FB55D8C

P2860

Effects of benefits and harms on older persons' willingness to take medication for primary cardiovascular prevention

http://www.wikidata.org/entity/Q35004412

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Effects of benefits and harms ...... mary cardiovascular prevention

@ast

Effects of benefits and harms ...... mary cardiovascular prevention

@en

type

label

Effects of benefits and harms ...... mary cardiovascular prevention

@ast

Effects of benefits and harms ...... mary cardiovascular prevention

@en

prefLabel

Effects of benefits and harms ...... mary cardiovascular prevention

@ast

Effects of benefits and harms ...... mary cardiovascular prevention

@en

P1433

Q35004412-B714BD8C-B416-4827-AA70-9048636835B1

P1476

Q35004412-A16F3C76-27F1-45F2-A5BB-BF708A092671

P2093

Q35004412-02497369-5528-4A3D-AC7C-0E66114877D6

Q35004412-5A7CFFCE-733E-4EED-B886-71F835E9E361

Q35004412-AFF9F1A8-6EF5-4618-B29E-3E89726B9907

Q35004412-D6CE63FA-CDAB-4EB0-AAD4-70CACC3AABDE

Q35004412-E3AA007A-F300-4B72-8593-6272E8F63182

P2860

Q35004412-08DB0B38-09CE-4598-8425-24E9B9103A88

Q35004412-10A235BC-2268-458B-9C11-930DC17EFDE3

Q35004412-19921C47-F3A9-4E22-A17C-B69A8DD36846

Q35004412-1FD2FCDE-CBF3-44D9-A3F8-8860DFA7302C

Q35004412-26B7D59E-1AD3-4733-963F-9A56DDCB0905

Q35004412-2F20D3FA-29EC-45A6-8CF1-09C06CD6D005

Q35004412-37282B98-8C68-4D5B-90F8-CFEEEE39184F

Q35004412-46D7FBFD-D5B7-4E69-847E-B2FADEC3D15D

Q35004412-4A462F63-3B60-40F1-BE13-B2855B3C6F63

Q35004412-506959E2-A4A0-4740-BE50-EF591F23EE04

P304

Q35004412-C09BA7D4-6A7F-48C4-9603-EC3C1D5F6E3E

P31

Q35004412-8822F069-D7DB-4EE9-842E-BD3BAFF50489

P356

Q35004412-37884566-B7CA-4CEB-9657-6A72D85E8324

P407

Q35004412-629578F3-81C2-4153-A841-4435AD3FE24C

P433

Q35004412-29760479-698F-4B10-BCFD-3DCCDD6E793C

P478

Q35004412-59527708-25FA-4D69-A546-77214F3E04A9

P577

Q35004412-AC8A1020-B48A-46D9-8B8F-7B38AD11FAE6

P5875

Q35004412-07221F21-12DD-4A11-A2E6-3EA109D835B6

P698

Q35004412-58DE9B36-525E-4020-AD9F-869E4DFD9E2B

P932

Q35004412-924A74EB-80D4-41FA-8DCA-261C70CA3FBD

P356

ARCHINTERNMED.2011.32

P1433

JAMA Internal Medicine

P1476

Effects of benefits and harms ...... mary cardiovascular prevention

@en

P2093

John R O'Leary

http://www.w3.org/2001/XMLSchema#string

Lynne Iannone

http://www.w3.org/2001/XMLSchema#string

Mary E Tinetti

http://www.w3.org/2001/XMLSchema#string

Terri R Fried

http://www.w3.org/2001/XMLSchema#string

Virginia Towle

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of Coronary Heart Disease Using Risk Factor Categories

A theory of medical decision making and health: fuzzy trace theory

Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision making

Patients' decisions about whether or not to take antihypertensive drugs: qualitative study.

How do patients' treatment preferences compare with those of clinicians?

Nonspecific medication side effects and the nocebo phenomenon.

The missing voice of patients in drug-safety reporting.

Views of older adults on patient participation in medication-related decision making.

Physician-patient communication about prescription medication nonadherence: a 50-state study of America's seniors.

Simple tools for understanding risks: from innumeracy to insight

P304

923-928

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHINTERNMED.2011.32

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

171

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50226898

http://www.w3.org/2001/XMLSchema#string

P698

21357797

http://www.w3.org/2001/XMLSchema#string

P932

3101287

http://www.w3.org/2001/XMLSchema#string